research alliance
MD Anderson, Turning Point Therapeutics Partner to Study Repotrectinib, Elzovantinib
The research will include preclinical and clinical studies of ROS1/NTRK inhibitor repotrectinib and MET inhibitor elzovantinib in several tumor types.
Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership
The partners will use Caris' MI Profile to analyze samples from metastatic castration-resistant prostate cancer patients in Sorrento's Phase II Maverick trial.
Avera Health, Sema4 Launch Five-Year Precision Oncology Study
The health system and the bioinformatics firm will sequence and provide PGx testing for as many as 15,000 patients in hopes of targeting cancer prevention and treatments.
Penn Medicine, CHOP to Support CAR T-Cell Research, Treatment in Costa Rica
The centers signed memoranda of understanding with Costa Rica's social security program focused on facilitating CAR T-cell therapy clinical trials in the country.
Drugmakers Come Together Hoping to Formalize MRD as Surrogate Endpoint in AML Trials
MPAACT members will share trial data, aiming to standardize measurable residual disease as a surrogate endpoint for overall survival and speed up drug development. Â